|Articles|February 1, 2022

AmerisourceBergen Releases 2021 Global Sustainability Report

COVID-19 response, global workforce both among highlights.

AmerisourceBergen released its 2021 Global Sustainability Report and Environmental, Social and Governance (ESG) Reporting Index, detailing the impact of its sustainability and community efforts. The report and ESG Reporting Index, which are available through a microsite, highlight AmerisourceBergen’s commitment to corporate responsibility and global sustainability and contain detailed information on ESG performance. For the fourth year in a row, selected information within the 2021 report was assured by ERM Certification and Verification Services.

Trending on PharmExec

AmerisourceBergen Releases 2021 Global Sustainability Report

Related Content

The New Healthy Aging Imperative and What It Means for Pharma

Reading Between the Lines: Closing the T1D Misdiagnosis Gap

Pharmaceutical Executive Daily: FDA Clears Trodelvy for First-Line Metastatic Triple-Negative Breast Cancer

Beyond the Strip: Las Vegas Has a New Kind of Venture in Mind

Novartis Announces $105 Million Collaborative Agreement with Antares Therapeutics

Trending on PharmExec

FDA Clears Trodelvy for First-Line Metastatic Triple-Negative Breast Cancer

The Rise of Direct-to-Patient Models in Pharma: Opportunities and Risks in Bypassing Traditional Distribution Channels

Novartis Announces $105 Million Collaborative Agreement with Antares Therapeutics

Ibrance Wins FDA Approval for HR-Positive, HER2-Positive Metastatic Breast Cancer Maintenance Therapy

Pharmaceutical Executive Daily: FDA Clears Trodelvy for First-Line Metastatic Triple-Negative Breast Cancer